January 11, 2016
Moderna Therapeutics Announces Transition to a Clinical Stage Company, Provides Business Update and Outlines 2016 Strategic Priorities
January 11, 2016
Moderna Licenses New Vaccine Candidates Against a New Viral Target to Merck
January 11, 2016
AstraZeneca and Moderna Therapeutics Announce New Collaboration to Co-Develop and Co-Commercialize Immuno-Oncology mRNA Therapeutics™
January 11, 2016
AstraZeneca and Moderna Therapeutics Announce New Collaboration to Co-Develop and Co-Commercialize Immuno-Oncology mRNA Therapeutics™
January 08, 2016
Moderna Therapeutics and PPD Announce Strategic Collaboration to Support Clinical Development of Novel mRNA Therapeutics
January 04, 2016
Moderna Therapeutics to Present at 2016 J.P. Morgan Healthcare Conference
December 15, 2015
Dr. Elizabeth Nabel Joins Moderna Therapeutics’ Board of Directors
December 15, 2015
Dr. Elizabeth Nabel Joins Moderna Therapeutics’ Board of Directors
October 22, 2015
Moderna Launches Caperna LLC, Its Fourth Venture, to Develop Personalized Cancer Vaccines
May 12, 2015
Moderna #1 on CNBC Disruptor 50 List

Pages